H-1337

N/A

Report date: 2024/08/28 20:00:53
NME

Base Information

Drug NameH-1337
Drug Alias NameH-1337ALY-1337
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinases inhibitors
TargetsProtein kinases
Therapy Area/IndicationsGlaucoma, Open-AngleOcular Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesD. Western Therapeutics Institute
China Registration ClassN/A

Develop Information

Active CompaniesD Western Therapeutics Institute Inc
Inactive CompaniesAllysta Pharmaceutical
Active IndicationsGlaucoma, Open-AngleOcular Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A